Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Connaught Laboratories: Service to the Empire

The Public Lab That Could Have Helped Fight COVID-19 Pandemic

Linda McQuaig

 by Toronto Star

Canada once had a publicly owned pharmaceutical company that could have made a difference in the current coronavirus crisis — except that we sold it.

Connaught Labs was a superstar in global medicine. For seven decades, this publicly owned Canadian company performed brilliantly on the national and international stage, contributing to medical breakthroughs and developing affordable treatments and vaccines for deadly diseases.

Hated by its corporate competitors, Connaught was unique among pharmaceutical companies in that its focus was on human need, not profit.

It would have come in handy today.

In fact, Connaught got its start amid a diphtheria outbreak in 1913. Toronto doctor John Gerald FitzGerald was outraged that children were dying in large numbers even though there was a diphtheria treatment available from a U.S. manufacturer. But, at $25 a dose, it was unaffordable to all but the rich. FitzGerald set out to change that — and did.

After experimenting on a horse in a downtown Toronto stable, FitzGerald developed an antitoxin that proved effective in treating diphtheria, and made it available to public health outlets across the country. Then, with lab space provided by the University of Toronto, he and his team went on to produce low-cost treatments and vaccines for other common killers, including tetanus, typhoid and meningitis.

Connaught developed an impressive research capacity, with its scientists contributing to some of the biggest medical breakthroughs of the 20th century — including penicillin and the Salk and Sabin polio vaccines. It also played a central role in the global eradication of smallpox.

“It was a pioneer in a lot of ways,” says Colleen Fuller, a research associate of the Canadian Centre for Policy Alternatives. “It did things commercial companies wouldn’t do because they weren’t willing to take the financial risks.”

Fuller argues that if a publicly owned Connaught were still operating today, it could be contributing to the development of the coronavirus vaccine — and ensuring a Canadian supply if there was a global shortage.

Yet, tragically it isn’t.

Succumbing to corporate pressure and a misguided belief that the private sector always does things better, Brian Mulroney’s Progressive Conservative government privatized Connaught Labs in the 1980s. Today, what remains of this once-dazzling Canadian public enterprise has been taken over by a giant French pharmaceutical company.

The coronavirus outbreak may finally help expose the fallacy of the notion that the private marketplace is innately superior — which has been the guiding principle in Anglo-American countries (including Canada) for the past four decades, leading to the constant denigration of government and its functions.

Fortunately, Canada’s public health care system, established in the 1960s, has been so popular that it has survived, despite attacks of “socialized medicine” — although our political leaders have quietly whittled away funding for the system in recent decades.

If the foolishness of cutting funding for public health care wasn’t already abundantly clear, the coronavirus has driven it home with a sledgehammer — as we’ve witnessed the extra struggles the U.S. faces in containing the virus with its lack of public health care.

Still, our willingness to go along with the privatization cult in recent decades has left us weaker and less protected than we could be.

Not only do we no longer have Connaught Labs, but Canada spends $1 billion a year funding basic medical research at Canadian universities, yet relies on the private marketplace to produce, control — and profit from — the resulting medical innovations.

For instance, the crucial work in developing a vaccine to treat Ebola was done by Canadian scientists at the National Microbiology Laboratory in Winnipeg — and financed by Canadian taxpayer money. But sole licensing rights to the vaccine were granted to a small U.S. company, which then sublicensed it to pharmaceutical giant Merck for $50 million.

Although Merck is now producing the vaccine, critics have charged that the company did “next to nothing” to rush the vaccine into production during the deadly Ebola outbreak in West Africa, according to a recent paper published in the Journal of Law and Biosciences.

With a surge in future global pandemics expected, it might well be time to rethink Canada’s foolhardy attachment to the notion “the private sector always does things better.”

Always unproven, that theory is looking increasingly far-fetched.


© 2020 TheStar.com
Linda McQuaig

Linda McQuaig

Linda McQuaig is an author, journalist, and former NDP candidate for Toronto Centre in the Canadian federal election. She is also the author of "The Sport and Prey of Capitalists: How the Rich Are Stealing Canada's Public Wealth" (2019), "War, Big Oil and the Fight for the Planet: It's the Crude, Dude" (2006) and  (with Neil Brooks) of "Billionaires’ Ball: Gluttony and Hubris in an Age of Epic Inequality" (2012).

... We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

'Global Empire of the US Christian Right': Dark Money Fuels Attacks on Abortion Rights Worldwide

The findings of a new investigation, said one observer, "further demonstrate the growing trend of religious extremists forging cross-border alliances" to gut abortion rights.

Jake Johnson ·


'Sad But Unsurprising': Biden Administration Rejects Calls for Ban on 'Killer Robots'

Campaigners warn that autonomous weapons systems pose "grave threats" worldwide.

Jake Johnson ·


AOC, Joyce Introduce Bipartisan Bill for 'Immediate Relief' From Cannabis Convictions

"Goes to show that lawmakers don't have to agree on everything to find common ground on solutions to the challenges facing everyday Americans."

Brett Wilkins ·


Green Groups Demand Answers About 'Flimsy' and Buried Biden Drilling Report

"Public records released as a result of this request will shine light on the dangerous chasm separating Biden's climate promises from his refusal to phase out the use of our public lands and waters for oil and gas extraction."

Jessica Corbett ·


'Protest Works': Cheers as Shell Signals Pullout of Cambo Oil Field Project

"We have to see the end of North Sea projects as well as all new fossil fuel extraction: There is no future in them."

Julia Conley ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo